Aumed, a.s., Komořanská 326/63, 143 14 Praha - Modřany, Česká republika

+420 603 587 701 English

AUMED, a.s. presented current research at the 45th ICMM World Congress on Military Medicine

AUMED representatives participated in the 45th ICMM World Congress on Military Medicine held in Brisbane, Australia. At the congress, AUMED participated as an active participant with a poster focused on the possible use of phages in war medicine. Our experts also presented the results of current research in the field of a newly prepared substance, leukocyte dialysate with a radioprotective effect.

IMG_8005 IMG_8012

MORE ARTICLES

AUMED, a.s. has received permission for a clinical trial, phase III, of the medicinal product TFI

16. 01. 2025

Based on the submitted application and the supplied documents, the State Institute for Drug Control (Czech Republic) has authorized a…

AUMED, a.s. successfully completed a clinical trial, phase I, of the medicinal product TFI

16. 01. 2025

AUMED, a.s. completed a clinical trial, phase I, of the medicinal product TFI (Transfer Factor) lyophilized mucoadhesive tablet for buccal-oral…

AUMED, a.s. presented current research at the 45th ICMM World Congress on Military Medicine

04. 10. 2024

AUMED representatives participated in the 45th ICMM World Congress on Military Medicine held in Brisbane, Australia. At the congress, AUMED…

Research projects of Aumed, a.s. are financed by the European Structural Funds and with financial support from the state budget through the Ministry of Industry and Trade. A complete list of all ongoing and completed projects with this support can be found here.

European Union
European Regional Development Fund
OP Enterprise and Innovation for Competitiveness


Tel.: +420 603 587 701
Komořanská 326/63, 143 14 Praha - Modřany, Česká republika
(c) 2017, Aumed a.s